These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8726528)

  • 1. A replication-deficient human immunodeficiency virus-1 genome as an interference-inducing provirus.
    Federico M; Nappi F; Mavilio F; Verani P
    Antibiot Chemother (1971); 1996; 48():217-25. PubMed ID: 8726528
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How 'elite controllers' tame HIV without drugs.
    Cohen J
    Science; 2020 Aug; 369(6507):1045. PubMed ID: 32855320
    [No Abstract]   [Full Text] [Related]  

  • 5. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
    Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B
    Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human immunodeficiency virus replication.
    Cullen BR
    Annu Rev Microbiol; 1991; 45():219-50. PubMed ID: 1741615
    [No Abstract]   [Full Text] [Related]  

  • 7. A system to analyze and identify inhibitors of HIV-1 gene regulation using a defective integrated provirus.
    Byrnes V; Hazuda D
    Methods Enzymol; 1996; 275():348-61. PubMed ID: 9026648
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospects for the control of AIDS patients by introducing defective-HIV harbouring leukocytes.
    Berencsi G; Minárovits J; Nász I; Földes I
    Med Hypotheses; 1989 Dec; 30(4):223-8. PubMed ID: 2693919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
    Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC
    Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.
    Beerens N; Groot F; Berkhout B
    Nucleic Acids Res; 2000 Nov; 28(21):4130-7. PubMed ID: 11058109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes.
    Ghosh SK; Fultz PN; Keddie E; Saag MS; Sharp PM; Hahn BH; Shaw GM
    Virology; 1993 Jun; 194(2):858-64. PubMed ID: 8503191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
    Ahmad N; Maitra RK; Venkatesan S
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of human immunodeficiency virus type-1 gene expression.
    Kingsman SM; Kingsman AJ
    Eur J Biochem; 1996 Sep; 240(3):491-507. PubMed ID: 8856047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
    Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nef alleles on replication of human immunodeficiency virus type 1.
    Zazopoulos E; Haseltine WA
    Virology; 1993 May; 194(1):20-7. PubMed ID: 7683154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.
    Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular basis for HIV infection: implication for the therapy].
    Nakaya T; Fujinaga K; Nishino Y; Kishi M; Ikuta K
    Tanpakushitsu Kakusan Koso; 1994 Jun; 39(8):1411-24. PubMed ID: 8016374
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-1 replication and potential targets for intervention.
    Stevenson M; Bukrinsky M; Haggerty S
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):107-17. PubMed ID: 1540400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.
    Rhodes A; James W
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():1965-74. PubMed ID: 2170567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.